Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance dataHong Ki Min, Jong Heon Park, Ho Jin Jeong et al.|Epidemiology and Health|2023Cited by 23
Intravenous Immunoglobulin Controls Th17 Cell-Mediated OsteoclastogenesisKyoung‐Woon Kim, Sang‐Heon Lee|Immune Network|2019Cited by 5